| Dr Roberta Haynes De Regt, MD | |
|
1135 116th Ave Ne, Suite 320, Bellevue, WA 98004-4623 | |
| (425) 688-8111 | |
| Not Available |
| Full Name | Dr Roberta Haynes De Regt |
|---|---|
| Gender | Female |
| Speciality | Obstetrics & Gynecology - Maternal & Fetal Medicine |
| Location | 1135 116th Ave Ne, Bellevue, Washington |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1134167620 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207VM0101X | Obstetrics & Gynecology - Maternal & Fetal Medicine | 025209 (Washington) | Primary |
| Entity Name | Obstetrix Medical Group Of Washington Inc Ps |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1861599573 PECOS PAC ID: 3577451947 Enrollment ID: O20040308000679 |
News Archive
Fate Therapeutics, Inc. announced today that the Company was named as one of Technology Review's 2010 TR50, the publication's first annual list of the 50 most innovative companies in the world. The 2010 TR50 companies span the fields of energy, computing, the Web, biomedicine, and materials and have been evaluated based on business model, strategies for deploying and scaling up its technologies and the likelihood of success. Each company in the 2010 TR50 has excelled not only at inventing technology but also at using it to transform how we live and work.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, for the treatment of diabetic neuropathy, a drug that has disease-modifying potential would earn 40 percent patient share in the U.S., according to surveyed U.S. neurologists. Similarly, in Europe, such a drug would earn a comparable patient share of 43 percent, according to surveyed European neurologists.
In a new trial, Swedish researchers will investigate if a medicine normally used to treat prostate cancer can also be used to treat COVID-19 in patients.
Some strains of the avian H7N9 influenza that emerged in China this year have developed resistance to the only antiviral drugs available to treat the infection, but testing for antiviral resistance can give misleading results, helping hasten the spread of resistant strains.
New research reveals that children born to women with rheumatoid arthritis face an increased susceptibility for certain chronic diseases. The findings, which appear in Arthritis Care & Research, should be used to increase awareness among pediatricians and general practitioners.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Roberta Haynes De Regt, MD 1135 116th Ave Ne, Suite 320, Bellevue, WA 98004-4623 Ph: (425) 688-8111 | Dr Roberta Haynes De Regt, MD 1135 116th Ave Ne, Suite 320, Bellevue, WA 98004-4623 Ph: (425) 688-8111 |
News Archive
Fate Therapeutics, Inc. announced today that the Company was named as one of Technology Review's 2010 TR50, the publication's first annual list of the 50 most innovative companies in the world. The 2010 TR50 companies span the fields of energy, computing, the Web, biomedicine, and materials and have been evaluated based on business model, strategies for deploying and scaling up its technologies and the likelihood of success. Each company in the 2010 TR50 has excelled not only at inventing technology but also at using it to transform how we live and work.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, for the treatment of diabetic neuropathy, a drug that has disease-modifying potential would earn 40 percent patient share in the U.S., according to surveyed U.S. neurologists. Similarly, in Europe, such a drug would earn a comparable patient share of 43 percent, according to surveyed European neurologists.
In a new trial, Swedish researchers will investigate if a medicine normally used to treat prostate cancer can also be used to treat COVID-19 in patients.
Some strains of the avian H7N9 influenza that emerged in China this year have developed resistance to the only antiviral drugs available to treat the infection, but testing for antiviral resistance can give misleading results, helping hasten the spread of resistant strains.
New research reveals that children born to women with rheumatoid arthritis face an increased susceptibility for certain chronic diseases. The findings, which appear in Arthritis Care & Research, should be used to increase awareness among pediatricians and general practitioners.
› Verified 4 days ago
Dr. Jill Rosetta Varni, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 9923 Lake Washington Blvd Ne, Bellevue, WA 98004 Phone: 425-505-2159 | |
Dr. Sarah Linse Bienenfeld, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1231 116th Ave Ne Ste 950, Bellevue, WA 98004 Phone: 425-454-6674 Fax: 425-646-5198 | |
Dr. Mark S Fan, MD Obstetrics & Gynecology Medicare: May Accept Medicare Assignments Practice Location: 1515 116th Ave Ne Ste 205, Bellevue, WA 98004 Phone: 310-866-3707 Fax: 425-999-4858 | |
Dr. Natalia Allison Dvorak, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1600 116th Ave Ne, #104, Bellevue, WA 98004 Phone: 323-857-3871 | |
Dr. Daniel Gavrila, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1135 116th Ave Ne, Suite #320, Bellevue, WA 98004 Phone: 425-688-8111 | |
Sara A Durkee, M.D. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 11511 Ne 10th St, Bellevue, WA 98004 Phone: 425-502-3000 |